Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
4 Results Found
Fact Sheet: 2025 Telehealth Advocacy Agenda
Given the pending expiration of several waivers, the AHA urges Congress to act to extend this critical lifeline for treatment and work towards a permanent pathway for provision of telehealth services.
Fact Sheet: 340B Drug Pricing Program: Fact vs Fiction
For nearly 30 years, the 340B Drug Pricing Program has provided financial help to safety-net hospitals to manage rising prescription drug costs. Section 340B of the Public Health Service Act requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to qualifying health care organizations that care for many uninsured and low-income patients.
Fact Sheet: COVID-19 Related Payer Mix Changes Threaten 340B Hospital Eligibility
The COVID-19 pandemic has altered hospitals’ payer mix, which for some hospitals has temporarily lowered their
disproportionate share hospital (DSH) percentage. These changes have unfortunately threatened the ability of some
hospitals to maintain their eligibility for the 340B program – a vital program that allows participating hospitals to stretch
their resources to provide comprehensive services to their patients.
Frequently Asked Questions Regarding ICD-10-CM Coding for COVID-19
Accurate coding is critical: AHA's ICD-10-CM FAQs address pneumonia icd10 & dizziness icd10 for precise COVID-19 documentation.